Zhongqi Dong, Ph.D. - Publications
Affiliations: | 2014 | Pharmaceutical Sciences | University of Maryland School of Medicine, Baltimore, MD, United States |
Area:
Pharmacy, Public Health, EpidemiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2015 | Dong Z, Li Q, Guo D, Shu Y, Polli JE. Synthesis and Evaluation of Bile Acid-Ribavirin Conjugates as Prodrugs to Target the Liver. Journal of Pharmaceutical Sciences. PMID 25645375 DOI: 10.1002/Jps.24375 | 0.537 | |||
2015 | Dong Z, Ekins S, Polli JE. A substrate pharmacophore for the human sodium taurocholate co-transporting polypeptide. International Journal of Pharmaceutics. 478: 88-95. PMID 25448570 DOI: 10.1016/J.Ijpharm.2014.11.022 | 0.553 | |||
2014 | Dong Z, Ekins S, Polli JE. Quantitative NTCP pharmacophore and lack of association between DILI and NTCP Inhibition. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 66: 1-9. PMID 25220493 DOI: 10.1016/J.Ejps.2014.09.005 | 0.563 | |||
2013 | Li Q, Guo D, Dong Z, Zhang W, Zhang L, Huang SM, Polli JE, Shu Y. Ondansetron can enhance cisplatin-induced nephrotoxicity via inhibition of multiple toxin and extrusion proteins (MATEs). Toxicology and Applied Pharmacology. 273: 100-9. PMID 24001450 DOI: 10.1016/J.Taap.2013.08.024 | 0.528 | |||
2013 | Li Q, Yang H, Peng X, Guo D, Dong Z, Polli JE, Shu Y. Ischemia/Reperfusion-inducible protein modulates the function of organic cation transporter 1 and multidrug and toxin extrusion 1. Molecular Pharmaceutics. 10: 2578-87. PMID 23651427 DOI: 10.1021/Mp400013T | 0.551 | |||
2013 | Dong Z, Ekins S, Polli JE. Structure-activity relationship for FDA approved drugs as inhibitors of the human sodium taurocholate cotransporting polypeptide (NTCP). Molecular Pharmaceutics. 10: 1008-19. PMID 23339484 DOI: 10.1021/Mp300453K | 0.568 | |||
Show low-probability matches. |